Inherited Disorders of Metabolism clinical trials at University of California Health
1 research study open to eligible people
“Assessing new blood cells growth after transplant using cord blood units that do not meet FDA guidelines but meet NMDP guidelines”
open to all eligible people
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
at UCLA UCSD UCSF
Our lead scientists for Inherited Disorders of Metabolism research studies include Thomas Martin.